NuVasive Inc. has announced increased net sales “driven by further adoption of new products and higher procedural volumes in the U.S.,” according to a company press release.
NuVasive reported net sales of 317.8 millions for the second quarter 2023. This is a 2.4% rise compared to the previous year. According to the press release, NuVasive also reported an operating margin of 5.7% under generally accepted accounting practices (GAAP), and GAAP earnings per share of $0.14.
“I’d like to congratulate our team on another solid quarter,” Chris Barry, CEO of NuVasive, said